Has Nils Guttenplan, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,373 in general payments to Nils Guttenplan, MD across 129 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nils Guttenplan, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nils Guttenplan, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nils Guttenplan, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1952399610

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.3%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 22.3%. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in NY, where the typical reported total is $18,433.

$14,373in general payments, 2019–2025

Across 129 payments — averaging $111.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biosense Webster, Inc.$3K
Boston Scientific$3K
Medical Device Business Services, Inc.$3K
Medtronic$2K
Abbott$2K
Biotronik Inc.$1K
plus $126 from 4 others

$61,209in research payments, 2019–2025

Across 347 payments — averaging $176.39 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Biotronik Inc.$61K

What the payments were for

Consulting fees$4,27530%
Speaking & faculty fees$2,10015%
Travel & lodging$1,89913%
Food & beverage$6,07842%
Education$210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biosense Webster, Inc.	27	$3,200
Boston Scientific	32	$3,069
Medical Device Business Services, Inc.	4	$2,925
Medtronic(2 entities)	21	$2,040
Abbott	23	$1,817
Biotronik Inc.	16	$1,197
AbbVie	3	$64
E.r. Squibb & Sons, L.L.C.	1	$28
Amgen	1	$22
Irhythm Technologies, Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Carto 3$4,752
EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$1,165
AVEIR$1,110
EMBLEM$1,050
EVERA MRI XT DR SURESCAN$904
Carto 3 System$750
NUVISION ICE CATHETER$406
Micra$310
AMVIA EDGE$230
Acticor 7 VR-T DX$210
ASSURITY$160
MyCareLink$154
AZURE XT DR MRI SURESCAN$150
BioMonitor$145
Farapulse$144
OCTARAY MAPPING CATHETER$143
Watchman$123
Claria MRI$121
Visitag$118
Assurity Pacemaker$107

How this compares

$14,373 in reported general payments places this provider in the 45th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$156,668

Medicare patients

457

Services billed

1,868

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	213	$220,565
XareltoRivaroxaban	35	$38,627
MultaqDronedarone Hcl	11	$23,011
Dofetilide	18	$8,978
Flecainide Acetate	171	$6,874
Metoprolol Succinate	190	$2,764
Amiodarone Hcl	158	$2,703
Diltiazem 24hr Er (Cd)Diltiazem Hcl	32	$1,213
Verapamil ErVerapamil Hcl	31	$416
Metoprolol Tartrate	41	$317
Digoxin	20	$316
Sucralfate	19	$194
ClopidogrelClopidogrel Bisulfate	18	$173
Pantoprazole Sodium	13	$80
Cephalexin	44	$80

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Srinivas DukkipatiNew York$2.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
James IpNew York$347K
Nicholas SkipitarisNew York$293K
Mohit TuragamNew York$202K
David LauNew York$202K
Christopher LiuNew York$181K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →